A prospective randomized controlled study of combined spinal-general anesthesia vs. general anesthesia for laparoscopic gynecological surgery: Opioid sparing properties |
| |
Affiliation: | 1. Department of Anesthesiology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China;2. Department of General Practice, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China;3. Department of Anesthesiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China;4. Department of Anesthesiology, Zhongda Hospital, Medical School of Southeast University, Nanjing 210009, China;1. School of Medicine, University of California, San Diego—9500 Gilman Drive, San Diego, CA 92093, United States of America;2. Department of Anesthesiology, Division of Regional Anesthesia and Acute Pain, University of California, San Diego, UCSD Medical Cent Hillcrest, 200 W. Arbor Drive, San Diego, CA 92103-8770, United States of America;3. Department of Medicine, Division of Biomedical Informatics, University of California, San Diego, San Diego - 9500 Gilman Dr. MC 0728, La Jolla, CA 92093-0728, United States of America |
| |
Abstract: | Study objectiveWe aimed to determine the magnitude of peri-operative opioid sparing effect when general anesthesia is combined with spinal analgesia for laparoscopic gynecological surgery.DesignA prospective randomized controlled study; a three-group trial with two comparisons (each intervention group to control).SettingOperating room and postoperative recovery area.PatientsPatients aged between 18 and 65 years with American Society of Anesthesiologists physical status 1 or 2 who were scheduled for inpatient elective laparoscopic gynecological surgery with expected pneumoperitoneum duration of at least 20 min. Of 102 randomized patients, 99 completed the study.InterventionsPatients were randomized to general anesthesia alone (control group) or combined with very-low-dose (levobupivacaine 3.75 mg; sufentanil 2.5 μg) or low-dose (levobupivacaine 7.5 mg; sufentanil 2.5 μg) spinal analgesia.MeasurementsPrimary endpoints were perioperative opioid consumption and pain scores (11-point numeric rating scale) at 30 min, 1 h, 2 h, 4 h and 24 h post-surgery. Secondary endpoints were patient satisfaction with anesthetic care and participation in research, sevoflurane consumption and adverse effects.Main resultsIntra-operative sufentanil (median [95% CI]) consumption was 16.1 (10.5–22.6) μg/h in the control group versus 4.7 (3.2–9.2) μg/h in the very-low-dose and versus 2.9 (0.0–4.0) μg/h in the low-dose spinal analgesia groups (p < 0.001, for both comparisons). Median (95% CI) piritramide consumption at 24 h post-surgery was 7.5 (3–8) mg in the control group versus 5 (0–7.5) mg in the very-low dose spinal analgesia group (p = 0.182) and versus 2 (0–2.5) mg in the low-dose spinal analgesia group (p = 0.001). Postoperative pain scores were consistently <3 only in the low dose spinal analgesia group. Patient satisfaction with anesthetic care and participation in research was very high in all groups.ConclusionsLow-dose spinal analgesia in combination with general anesthesia reduces peri-operative opioid consumption in laparoscopic gynecological surgery in immediate postoperative period. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|